It appears that NF-kB inhibitors and TLR4 agonists lead to the suppression of HMGB1 and decreases in IL-6 levels, demonstrating their involvement in endometriosis and the clinical relevance of this new finding. The gene discussed is HMGB1; the disease is endometriosis.